Sabri Thabit Saleh Ahmed

Epernicus is a professional networking platform tailor-made for scientists, aiming to connect researchers globally through detailed profiles and real-world networks to advance their work. What sets Epernicus apart is its focus on highlighting key aspects of a scientist's career, including training, publications, and mentorship history. Additionally, the platform automatically compiles a scientist's real-world network, including research groups, departments, institutions, and alumni connections. Scientists using Epernicus can specify their expertise, facilitating easier discovery of collaborators with specialized skills and enabling connections between scientists from academia, private industry, and government research institutions. Founded in 2007, the platform's co-founders and team bring diverse expertise, including medical training, neuroscience-focused medical technology, and technology development for web, television, and mobile devices. The co-founders of Epernicus include Vivek Murthy, MD, MBA, who is also an attending physician at Brigham and Women's Hospital and an instructor at Harvard Medical School. Mikhail Shapiro, Ph.D., co-founded Cyberkinetics Neurotechnology Systems, Inc., and completed his PhD at MIT. Eric Silberstein was previously the founder and Chairman of Idiom Technologies (acquired by SDL), while Ezra Freedman was formerly VP of Technology for Schematic, an interactive agency in Los Angeles. The platform serves the Biotechnology and Health Care industries, providing an invaluable resource for researchers in these fields. For investors seeking opportunities in the biotechnology and health care sectors, Epernicus presents a unique platform with potential for fostering collaboration and advancing scientific research on a global scale. Leveraging the expertise of its co-founders and the growing demand for specialized scientific networking platforms, Epernicus holds promise for future growth and impact in the scientific community.